BAIN CAPITAL INVESTORS LLC

13F Filings History

Latest 13F report
Q2 2024 - Aug 12, 2024
Value $
$4.71B
Signature - Title
Michael D. Ward - Partner of Bain Capital Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent 13F filings made by BAIN CAPITAL INVESTORS LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BAIN CAPITAL INVESTORS LLC reported 5 stock holdings with total value $4.71B as of Q2 2024. Top holdings included CERE, SGRY, WAY, AVAH, and ADV.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q2 2024 5 $4.71B +$602M $0 +$602M CERE, SGRY, WAY, AVAH, ADV 13F-HR 8/12/2024, 01:30 PM
Q1 2024 4 $4.48B $0 $0 CERE, SGRY, AVAH, ADV 13F-HR 5/15/2024, 10:30 AM
Q4 2023 4 $4.61B +$232M -$266M -$33.2M CERE, SGRY, AVAH, ADV 13F-HR 2/13/2024, 04:30 PM
Q3 2023 4 $3.12B $0 -$1.99B -$1.99B SGRY, CERE, AVAH, ADV 13F-HR 11/14/2023, 04:00 PM
Q2 2023 5 $6.67B $0 -$13.8M -$13.8M SGRY, DSEY, CERE, AVAH, ADV 13F-HR 8/14/2023, 04:31 PM
Q1 2023 5 $5.49B +$3.41M $0 +$3.41M SGRY, DSEY, CERE, AVAH, ADV 13F-HR 5/15/2023, 04:48 PM
Q4 2022 5 $4.61B +$256M $0 +$256M CERE, SGRY, DSEY, AVAH, ADV 13F-HR 2/14/2023, 07:12 AM
Q3 2022 5 $4.14B $0 $0 CERE, DSEY, SGRY, AVAH, ADV 13F-HR 11/14/2022, 04:00 PM
Q2 2022 5 $4.78B $0 $0 CERE, DSEY, SGRY, AVAH, ADV 13F-HR 8/15/2022, 07:46 AM
Q1 2022 5 $6.91B $0 $0 SGRY, CERE, DSEY, AVAH, ADV 13F-HR 5/16/2022, 04:01 PM
Q4 2021 5 $8.36B +$7.04M -$148M -$141M DSEY, SGRY, CERE, AVAH, ADV 13F-HR 2/14/2022, 08:34 AM
Q3 2021 6 $8.48B $0 -$4.02M -$4.02M DSEY, SGRY, CERE, AVAH, IQV 13F-HR 11/15/2021, 04:08 PM
Q2 2021 7 $10.2B +$2.51B -$1.16B +$1.35B DSEY, SGRY, CERE, AVAH, IQV 13F-HR 8/16/2021, 04:23 PM
Q1 2021 7 $6.8B +$3.48B -$30.9M +$3.45B DSEY, SGRY, MIK, CERE, IQV 13F-HR 5/17/2021, 06:58 AM
Q4 2020 7 $2.64B +$1.04B -$29.1M +$1.01B CERE, SGRY, MIK, IQV, ADV 13F-HR 2/16/2021, 09:01 AM
Q3 2020 5 $1.22B $0 -$14.8M -$14.8M SGRY, MIK, IQV, VRTV, ATTO 13F-HR 11/16/2020, 08:01 AM
Q2 2020 5 $816M $0 -$55.2M -$55.2M MIK, SGRY, IQV, VRTV, ATTO 13F-HR 8/14/2020, 08:00 AM
Q1 2020 5 $400M $0 -$83.3M -$83.3M SGRY, MIK, IQV, ATTO, VRTV 13F-HR 5/15/2020, 08:00 AM
Q4 2019 5 $1.25B $0 -$509M -$509M MIK, SGRY, IQV, ATTO, VRTV 13F-HR 2/14/2020, 08:08 AM
Q3 2019 7 $1.61B +$8.83M -$505M -$496M MIK, G, IQV, SGRY, ATTO 13F-HR 11/14/2019, 08:36 AM
Q2 2019 6 $2.07B $0 -$377M -$377M G, MIK, IQV, SGRY, ATTO 13F-HR 8/14/2019, 09:04 AM
Q1 2019 7 $2.62B $0 -$436M -$436M G, MIK, SGRY, IQV, ATTO 13F-HR 5/15/2019, 09:00 AM
Q4 2018 7 $2.72B $0 -$98.1M -$98.1M G, MIK, IQV, SGRY, ATTO 13F-HR 2/14/2019, 08:30 AM
Q3 2018 7 $3.57B $0 -$54.6M -$54.6M G, MIK, IQV, SGRY, ATTO 13F-HR 11/14/2018, 06:46 AM
Q2 2018 7 $3.53B $0 -$158M -$158M G, MIK, SGRY, IQV, ATTO 13F-HR 8/14/2018, 07:04 AM
Q1 2018 7 $3.91B $0 -$421M -$421M G, MIK, IQV, SGRY, ATTO 13F-HR 5/15/2018, 07:23 AM
Q4 2017 8 $4.51B +$529M -$1.47B -$943M G, MIK, IQV, ATTO, BFAM 13F-HR 2/14/2018, 06:34 AM
Q3 2017 10 $5.16B +$274M -$609M -$335M G, MIK, ATTO, BFAM, Q 13F-HR 11/14/2017, 07:02 AM
Q2 2017 10 $5.19B $0 -$427M -$427M G, MIK, Q, ATTO, BFAM 13F-HR 8/14/2017, 08:10 AM
Q1 2017 10 $5.39B +$7.38K -$93.2M -$93.2M G, MIK, BFAM, Q, ATTO 13F-HR 5/15/2017, 07:31 AM
Q4 2016 10 $5.17B +$105M -$233M -$128M G, MIK, BFAM, Q, ATTO 13F-HR 2/14/2017, 07:23 AM
Q3 2016 9 $5.55B +$21.3M -$966M -$945M G, MIK, BFAM, Q, ATTO 13F-HR 11/14/2016, 06:13 AM
Q2 2016 11 $6.69B $0 -$649M -$649M MIK, G, BFAM, TSE, Q 13F-HR 8/15/2016, 08:21 AM
Q1 2016 12 $7.1B +$1.77M -$720M -$718M MIK, G, BFAM, TSE, Q 13F-HR 5/16/2016, 08:38 AM
Q4 2015 11 $7.17B +$301M -$245M +$56M MIK, G, BFAM, TSE, Q Restatement 3/16/2016, 02:37 PM
Q3 2015 10 $7.02B $0 -$1.6B -$1.6B MIK, G, BFAM, TSE, Q 13F-HR 11/13/2015, 06:40 AM
Q2 2015 11 $9.02B $0 -$1.61B -$1.61B MIK, BFAM, G, TSE, HDS 13F-HR 8/14/2015, 09:59 AM
Q1 2015 13 $9.99B +$419M -$781M -$362M MIK, G, BFAM, Q, HDS 13F-HR 5/15/2015, 10:02 AM
Q4 2014 13 $9.36B +$655M -$2.96B -$2.3B MIK, BFAM, G, Q, HDS 13F-HR 2/17/2015, 09:06 PM
Q3 2014 12 $9.97B +$1.82B -$704M +$1.11B BURL, BFAM, MIK, Q, HCA 13F-HR 11/14/2014, 04:00 PM
Q2 2014 11 $8.75B +$775M -$2.73B -$1.95B BFAM, BURL, Q, G, HCA Restatement 11/6/2014, 01:05 PM
Q1 2014 11 $10.1B $0 -$907M -$907M BURL, HCA, BFAM, ST, G 13F-HR 5/15/2014, 09:17 AM
Q4 2013 11 $10.6B $0 $0 BURL, BFAM, HCA, BLMN, ST 13F-HR 2/10/2014, 04:52 PM